ADAI News & Events
May 23, 2023
Transforming Our Communities Annual Gathering (June 27-28): Registration is OPEN!
Registration is now open for this year’s Transforming Our Communities gathering, to be held virtually and in-person on June 27-28, 2023! This annual 2-day event aims to bring diverse participants together to understand the perspectives of people who use drugs, understand the importance of equitable access to care and services, build partnerships and connect people…
April 27, 2023
SBIRT Job Openings at 2 Emergency Departments in King County
St Francis Hospital in Federal Way, WA and Harborview Medical Center in Seattle, WA have full-time openings on their respective Screening, Brief Intervention, and Referral to Treatment (SBIRT) teams. SBIRT is paid for by King County’s MIDD Behavioral Health Sales Tax Fund which is specifically for programs and services for people living with or at…
Commentary Series About High-THC Cannabis in Addiction Sparked by Piece from ADAI’s Beatriz Carlini, PhD, MPH
ADAI Acting Associate Professor Beatriz Carlini, PhD, MPH, Director of our Cannabis Education & Research Program (CERP), co-authored a paper published last January in the journal Addiction titled “How should policymakers regulate the tetrahydrocannabinol content of cannabis products in a legal market?” (Hall W, Leung J, Carlini BH. Addiction 2023 (in press)). The paper discusses…
April 25, 2023
KUOW Interview with Dr. Caleb Banta-Green on the WA Legislature’s Failure to Pass SB 5536 (Drug Possession Law)
Last weekend, the Washington State legislature failed to pass SB 5536, a replacement for the state’s drug possession law, which will time out in July. If things are left as they are, and a special legislative session isn’t called to try to get the bill passed, not only will drug possession be legal in the…
April 24, 2023
Lunch & Learn: Building Inclusive Data Visualizations [From Data Collection to Presentation of Results] (May 16, 12pm PT)
Join ADAI for our next Lunch & Learn session, may 16, 2023 (12-1pm PT) this time featuring UW Data Visualization Librarian Negeen Aghassibake on inclusive data visualization for any type of research or information. This session will bring forward questions about visualizing data with inclusion as a primary value and push against established best practices. This session…
April 19, 2023
Ask an Expert: What are “High THC” Cannabis Products and What Policies Could Help Limit Harm from Their Use?
Meet our expert Beatriz Carlini, PhD, MPHDirector, ADAI Cannabis Education and Research Program What are high-THC concentration cannabis products? How much THC is considered “high-THC”? Tetrahydrocannabinol (THC) is the best-known psychoactive ingredient in the cannabis plant–the ingredient that causes people to feel “high.” High-THC cannabis concentrates include things like shatter, wax, butters and oils used…
April 18, 2023
Detailed Fentanyl Drug Testing Results for King County (WA Medical Examiner Samples)
“Detailed fentanyl drug testing results for King County, WA Medical Examiner samples” is a new handout on the StopOverdose.org website with photos of drugs and detailed chemical analyses. Results show a broad range of fentanyl content and highly variable appearances. In February 2023, the King County Medical Examiner sent 12 fentanyl samples to the Drug…
April 6, 2023
Webinar: Harm Reduction: Past, Present & Future (April 12, 12pm PT)
This event has passed. Find the recording below. Join the Northwest ATTC on April 12, 2023 (12-1pm PT) for our next webinar: Harm Reduction: Past, Present & Future, presented by Paul LaKosky, PhD (Executive Director of Dave Purchase Project, Tacoma, WA). In this session, Dr. LaKosky will present a brief, admittedly incomplete, description of the…
March 29, 2023
NEW: U.S. FDA Approves Narcan (4mg Naloxone Nasal Spray) for Over-The-Counter Purchase/Use
From the US FDA press release: Today, the U.S. Food and Drug Administration approved Narcan, 4 milligram (mg) naloxone hydrochloride nasal spray for over-the-counter (OTC), nonprescription, use – the first naloxone product approved for use without a prescription. Naloxone is a medication that rapidly reverses the effects of opioid overdose and is the standard treatment…
March 28, 2023
Recording available: ADAI Lunch & Learn: Addressing the Risks of High THC Cannabis (now on April 20, 12pm PT)
This event has passed. Find the recording below. Join us on April 20, 2023 (12-1pm PT) for our next ADAI Lunch & Learn: Addressing the Risks of High-THC Cannabis: The Public Health and Legislative Saga Presenters: Beatriz Carlini, PhD, MPH, Sharon Garrett, MA, MPH, Lexi Nims, BA (ADAI Cannabis Education & Research Program) With cannabis…
Next page
